ARDS, HUMAN
Clinical trials for ARDS, HUMAN explained in plain language.
Never miss a new study
Get alerted when new ARDS, HUMAN trials appear
Sign up with your email to follow new studies for ARDS, HUMAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New anticoagulation strategy tested for dialysis circuits in ECMO patients
Disease control CompletedThis study tested whether adding regional citrate anticoagulation (RCA) to standard heparin can reduce clotting in continuous kidney dialysis circuits for patients on ECMO. Eighteen ICU adults with ARDS and acute kidney injury were enrolled. Each patient received alternating peri…
Matched conditions: ARDS, HUMAN
Phase: NA • Sponsor: University of Milano Bicocca • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Experimental cell treatment shows promise for COVID-19 lung failure
Disease control CompletedThis early-stage study tested a single dose of mesenchymal stromal cells in 7 COVID-19 patients with severe acute respiratory distress syndrome (ARDS) who were on ventilators. The main goal was to check safety, looking for serious side effects like heart problems or blood clots w…
Matched conditions: ARDS, HUMAN
Phase: PHASE1 • Sponsor: Uppsala University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Smart lung pressure strategy tested in 676 ICU patients
Disease control CompletedThis study tested whether using a special imaging technique (EIT) to set breathing machine pressure helps people with severe lung injury (ARDS) survive longer compared to using a standard pressure table. Over 600 adults on breathing machines took part. The main goal was to see if…
Matched conditions: ARDS, HUMAN
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Blood filtering shows promise for severe COVID-19 patients
Disease control CompletedThis study tested whether filtering the blood (therapeutic plasma exchange) could help severe COVID-19 patients by removing harmful immune molecules that cause lung damage. Twenty-one adults in intensive care with COVID-19 and lung failure were randomly assigned to receive either…
Matched conditions: ARDS, HUMAN
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 26, 2026 13:04 UTC
-
New ventilator approach studied in ARDS patients
Knowledge-focused CompletedThis study looked at a new way to set breathing machines for people with severe lung injury (ARDS). The method uses pressure measurements inside the lungs to adjust settings. Nine adults took part to see if the approach is safe and works well. The goal was to learn more, not to c…
Matched conditions: ARDS, HUMAN
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC